AKC CHF Partners with All Access for Canine Science TV
RALEIGH, NC, March 30, 2026 The AKC Canine Health Foundation (CHF) has announced a strategic collaboration with the educational...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
RALEIGH, NC, March 30, 2026 The AKC Canine Health Foundation (CHF) has announced a strategic collaboration with the educational...
Ann Arbor, Michigan, March 16, 2026 Zomedica Corp., a leading provider of veterinary diagnostic and therapeutic solutions, reported record...
PARSIPPANY, N.J. — December 11, 2025 — Zoetis Inc., the world’s leading animal health company, announced that its Board...
Reykjavik & London, November 2025 Alvotech and Advanz Pharma have received marketing approval across the European Economic Area (EEA)...
Dateline – November 17 2025 | Minneapolis & Miami PetVivo Holdings, Inc. announced that its exclusive AI-technology partner, Digital...
INDIANAPOLIS, Ind., October 24, 2025 — In a landmark decision for veterinary medicine and regulatory preparedness, Elanco Animal Health...
